and will co-ordinate with our European campuses’ international executive programmes for professionals and companies taught by our international panel of lecturer’s.
Read our wellcome Board Letter 2023
The objective of the online international course is to accelerate our alumni their career development into higher management positions in the biopharmaceutical industry and across the wider life sciences sector.
The one-year, part-time curriculum will provide full immersion into drug discovery processes, life science research, medical technologies and healthcare management worldwide. The Executive MBA in Healtcare is a one-year, part-time executive master’s programme that will be taught in coordination with Barcelona and Cambridge.
The course is designed for scientists who want to develop their careers in applied research and continue their professional development in the biopharmaceutical industry and the wider life sciences sector.
For more information click here
Our executive education for organisations help to develop teams to achieve business excellence and their corporate goals.
Our panel of industry experts, coming from more than 20 countries, cover key management topics in the healthcare industry including market access and healthcare economics, preclinical and clinical regulatory requirements, medical technologies, corporate finance, technology transfer and entrepreneurship, organizational behaviour, and an understanding of the global strategy for new drug approvals.
We also develop business development activities such as events, summits, and forums amongst key stakeholders from the biotechnology sector and the pharmaceutical industry increasing their international knowledge and network with healthcare leaders.
For more information click here
Our presence in Mexico has allowed us to become the first business school in Latin America specialised in healthcare with a focus in international development of professionals in healthcare, biotechnology and the overall business scientific community.
The Mexico Programmes are taught by a panel of experienced lecturers, who have worked in the Healthcare, Biotechnology & Pharmaceutical industry and have the practical experience of commercialising technology and innovation in the major markets.
The Mexico team will also draw on the Barcelona and Cambridge lecturers for some of the teaching and will teach a broader remit across borders about the whole healthcare sector. The Mexico Campus will have its own wellbeing officer to support students' needs during their courses.
Key international partners, such governmental organisations, bioindustry associations, companies and trade bodies, enable the Biotechnology Business Institute extend its global reach from Barcelona, Cambridge, Mexico and beyond.
Instituto de Biotecnología de la FCB
Col 20, 66455 San Nicolás de los Garza, N.L., Mexico
contact email: firstname.lastname@example.org
Here are some of the most frequent questions from our candidates
Our complementary MBA programmes in Biotechnology and in Life Sciences enable scientists to enter this growing industrial sector each year. We help our students develop a clear vision of their career progression into future leadership roles. By using the new skills and practical experiences from our courses, our alumni go on to join the some of the most notable institutions, companies and national healthcare systems with international reputations.
With a presence in two of the main innovation centres in Europe, Barcelona, and Cambridge, and the second largest market in the pharmaceutical industry in Latin America our students can choose which campus will best meet their needs.
As the International BBI headquarters, the Barcelona Campus is focused on drug discovery, built on a track record since 2013 delivering management programmes for scientists wanting to develop their careers in the global pharma & biotechnology industry.
The European headquarters, our Cambridge Campus, has a broader remit across the entire Life Science sector. At Cambridge, UK, our students can realise their objective of establishing a global network of contacts in the broader spectrum of commercial opportunities in Life Sciences.
Know more about our campuses
The Biotechnology Business Institute (BBI) is an international business school focused on training a new generation of scientific managers and executives to prepare for their future careers. The BBI facilitates early-stage business development activities in partnership with the many stakeholders in the biotechnology sector and the pharmaceutical industry worldwide. A core focus is on new drug development to treat unmet medical need but also with broadening interests across the Life Sciences sector.
The Biotechnology Business Institute was founded to develop the next generation of talent in the international Life Sciences sector for scientists seeking to advance their careers in the pharmaceutical and biotechnology industries. We are committed to becoming a leading international academic institution in the management of Life Sciences, through enabling the career development of a new wave of global business leaders driving disruptive change throughout the ecosystem.
Every day is different throughout the year. During the first stage, when students take their common modules, apart from the evening classes from Monday to Thursday, the students also develop their career impact programmes. These programmes have their project meetings at various research centres and participate in extra-curriculum activities.
For the final semester in Barcelona, each student develops their own academic internship programme depending on their chosen career itinerary chosen. All programmes have the same number of assignments and group work to complete. Typically, the second semester is focused increasing the time spent on students’ career-related activities.
The BBI network is formed by our alumni, the academic staff, lecturers, partner companies and the technology transfer offices who collaborate with us. Over the years, we have developed a community over 700 people globally in direct contact every year.
For more information, visit our BBI community Report